Nobiletin has demonstrated its ability to enhance PD-1 mAb treatment, promoting cytokine secretion in peripheral blood mononuclear cells (PBMC) and inducing greater tumor cell death (185). This evidence concerns the gene PDCD1 and neoplasm.